pancreatic cancer – Page 2 – Discover Pharma

Welcome to Discover Pharma! Today is : October 25, 2026

pancreatic cancer

Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events
Anocca raises SEK 440M to advance TCR-T cell therapies into clinical development
Swedish clinical-stage biotech Anocca AB has secured approximately SEK 440 [...]

May 5, 2026
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
Mainz Biomed targets US approval for next-gen CRC test and expands into pancreatic cancer
Mainz Biomed says it is preparing to launch a pivotal [...]

May 5, 2026
Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Opinion & Events,Therapeutic Areas
Can cryoablation plus intratumora immunotherapy rewrite the rules of cancer treatment?
Q&A with Dr Jason Williams, founder of the Williams Cancer [...]

May 5, 2026
Drug Discovery & Development,Therapeutic Areas
Mainz Biomed launches feasibility study to assess pancreatic cancer biomarker panel
Mainz Biomed has initiated a feasibility study as part of [...]

May 5, 2026
Advanced Therapies,Drug Delivery & Formulation
Generic Paclitaxel launch expands US access to chemotherapy for metastatic cancer
Meitheal introduces albumin-bound injectable version under license from Hong Kong [...]

May 5, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK